ELOCTATE

This brand name is authorized in Brazil, Canada, Hong Kong, Japan, New Zealand

Active ingredients

The drug ELOCTATE contains one active pharmaceutical ingredient (API):

1 Coagulation factor VIII UNII 839MOZ74GK - ANTIHEMOPHILIC FACTOR HUMAN

Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X (factor Xa). Haemophilia A is a sex-linked hereditary disorder of blood coagulation due to decreased levels of factor VIII:C. By replacement therapy the plasma levels of factor VIII are increased, thereby enabling a temporary correction of the factor deficiency and correction of the bleeding tendencies. Read about Coagulation factor VIII

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ELOCTATE Powder for solution, lyophilized	Health Products and Food Branch (CA)	MPI, CA: SPM

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BD02	Coagulation factor VIII	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 538318010002207, 538318010002307, 538318010002407, 538318010002507, 538318010002607, 538318010002707, 538318010002807, 576720070079717, 576720070079817, 576720070079917, 576720070080017, 576720070080117, 576720070080217, 576720070080317
Country: CA	Health Products and Food Branch	Identifier(s): 02430290, 02430304, 02430312, 02430320, 02430339, 02430347, 02430355
Country: HK	Department of Health Drug Office	Identifier(s): 66994, 66995, 66996, 66997
Country: JP	医薬品医療機器総合機構	Identifier(s): 6343442D1022, 6343442D2029, 6343442D3025, 6343442D4021, 6343442D5028, 6343442D6024, 6343442D7020, 6343442D8027
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 17412, 17413, 17414, 17415, 17416, 17417, 17422